Bone Graft Substitute Market: Information by Product Type (Allograft, Bone Graft, Substitute, Cell-based Matrices), by Application (Spinal Fusion, Joint Reconstruction, Long Bone, Dental, Foot & Ankle), and by Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Forecast 2027

ID: VPR/HC/1048 Publishing Year: November 2021 Pages: 105 Format:   


Bone Graft Substitute Market Overview:

Bone Grafting is a surgical process in which deficient Bone is replaced. In bone grafting treatments, various types of Bone Grafts are employed, including autologous bone grafts, allografts, and synthetic Bone Grafts. A method of interdigitation and envelopment of the donor bone tissue with the new bone formed by the recipient can be regarded as the incorporation of a bone transplant. It's a multipurpose product that uses natural mechanisms to repair damaged bone tissue and promote bone growth. The most successful types of Bone Grafts are natural Bone Grafts, which are regarded the gold standard for replacing lost bones. Bone Grafts are utilised for a variety of objectives, including filling voids caused by cysts, tumours, or other causes, stimulating the healing of fractures that have failed to mend after a first treatment effort, and more.

In orthopaedic operations, Bone Grafts are commonly used. Elective surgeries were postponed or cancelled during the Covid-19 Pandemic, and the majority of elective surgeries were postponed or cancelled. As a result, demand for orthopaedic surgery products such as bone grafts and substitutes has dropped dramatically. In addition, protracted factory closures by market players in several countries hampered the device's production. Bone Grafting is a technical term for a surgical process in which replacement material is used to mend fractured bones, such as fractures or holes in bones.

Key Players:

  • ACE Surgical Supply Company, Inc. (US)
  • BioHorizons (US)
  • Dentium (South Korea)
  • DentsplySirona (US)
  • InstitutStraumann AG (Switzerland)
  • Medtronic (Ireland)
  • Stryker (US)
  • Zimmer Biomet (US)

Covid-19 Impact:

The overall Impact Of The Covid-19 Pandemic on Medical Device Businesses in the Bone Grafts & Substitutes Industry is anticipated to be unfavourable. Companies are experiencing a setback as a result of the lockdown, which has caused supply chain problems all across the world. Furthermore, important industry participants are having difficulty finding human resources to manufacture Bone Grafts and Substitutes at manufacturing sites. In addition, end users like as hospitals and clinics have reported a decrease in patient visits as a result of the global lockdown limitations. However, the situation is anticipated to improve as governments around the world begin to reduce regulations to allow businesses to resume operations. Furthermore, following the resumption of elective operations and treatments in the near future, demand for Bone Grafts and Substitutes is expected to rise.

Market Drivers:

The rising number of occurrences of bone and joint problems has been identified as a crucial factor that could boost market expansion throughout the forecast period. The market is expected to grow due to rising acceptance of dental Bone Transplants and ongoing technological advancements. In the next years, the growing need for high-quality musculoskeletal function among the ageing population is likely to considerably fuel the market.

Opportunities:

In the future years, the launch of biocompatible synthetic Bone Grafts, as well as ongoing technological advancements in the field, are projected to provide a variety of market expansion prospects. Furthermore, prominent companies' increased focus on R&D activities is expected to give different chances for market expansion over the forecast period.

Market Segmentation:

Allografts, Bone Graft Substitutes, and cell-based matrices are the three product categories in the Bone Grafts and Substitutes Market. Machined allografts and demineralized bone matrix are the two types of allografts. Bone morphogenic proteins (BMP) and synthetic Bone Grafts are separated from the Bone Graft Substitute Market Category. During the projected period, the bone graft substitutes segment is expected to dominate the market. The rise in the prevalence of bone and joint problems is to blame. Furthermore, these bone graft substitutes are employed for a variety of purposes, including bone replacement, posttraumatic skeletal disorders, and other bone-related issues. Furthermore, advances in Bone Graft Materials and the creation of novel products drive the growth of the Bone Grafts and Substitutes Market.

Regional Analysis:

During the projected period, the Market for Bone Graft Substitute Market in Asia Pacific is expected to develop at a healthy rate. This expansion can be linked to an increase in medical tourism as well as favourable government policies. Stringent regulatory limitations, on the other hand, limit use in a few countries. In South Korea, for example, the Korean Food and Drug Administration must approve the product before it can be sold (KFDA). The Therapeutic Goods Administration regulates the items in Australia (TGA). Foreign players are restricted from entering Japan due to the country's rigorous regulatory environment. With the recent approval of DBM in Japan in 2019, the allograft market in Asia Pacific is expected to increase significantly over the coming decade.



Frequently Asked Questions
The rising number of occurrences of bone and joint problems has been identified as a crucial factor that could boost market expansion throughout the forecast period.
ACE Surgical Supply Company, Inc. (US) ,BioHorizons (US) ,Dentium (South Korea) ,DentsplySirona (US) ,InstitutStraumann AG (Switzerland) ,Medtronic (Ireland)Stryker (US) ,Zimmer Biomet (US)

Type Here for table of content.


PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]
PURCHASE OPTIONS




    ADD TO CART

CONTACT US
CALL US ON
( +91-935-919-4956 )

CONTACT EMAIL
[email protected]